DXCM today
$80.34+$0.42 (+0.53%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourExpanding
1 hourBullish
15 minSymmetric Triangle
5 minConsolidating
Daily trend turns up above $90.39
Key levels
Resistance$86.75
Resistance$82.86
Support$76.52
Support$73.10
Latest news & SEC filings
SEC FilingDexcom Inc filed an insider trading report (Form 4)
All DXCM news →About Dexcom
Dexcom makes wearable sensors that track glucose levels continuously for people managing diabetes and related metabolic conditions. Its offerings include the G7, G7 15 Day, G6, Dexcom ONE+, and Stelo, a non-prescription biosensor sold in the U.S. Buyers include individuals with diabetes, their families, and healthcare providers. The firm sells across the U.S. and numerous countries in Europe, Asia, and Latin America.
Based on the company's 10-K filed Feb 12, 2026.
Nasdaq · Healthcare
DEXCOM INC (DXCM)
What Is the Price Target for DXCM?
SEPT Low Target
$82.00
SEPT Mid Target
$95.00
SEPT High Target
$120.00
Analyst Consensus
$95.00
Is DXCM a Buy or Sell Right Now?
Thesis
- •Revenue growing 15.6% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for DXCM.
Start Free Trial →Is DXCM Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$83.21
72
Moat Score
WIDE
8/9
Piotroski Score
7.5
Altman Z-Score
What Is Smart Money Doing with DXCM?
Insider Signal
SELLING
0 buys / 12 sells (90d)
Congress Signal
BUYING
6 buys / 4 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Brown Michael Jon | officer | Sale | 1,451 | $115K | Nov 8, 2026 |
| Leach Jacob Steven | director officer | Sale | 1,451 | $115K | Nov 8, 2026 |
| Stern Sadie | officer | Sale | 1,451 | $115K | Nov 8, 2026 |
| Sylvain Jereme M | officer | Sale | 1,451 | $115K | Nov 8, 2026 |
| Ashley Euan A. | director | Sale | 2,389 | - | Oct 30, 2026 |
| Stern Sadie | officer | Sale | 2,565 | $202K | Oct 27, 2026 |
| Stern Sadie | officer | Sale | 2,565 | $221K | Sep 28, 2026 |
| Stern Sadie | officer | Sale | 2,565 | $227K | Aug 27, 2026 |
| Leach Jacob Steven | director officer | Sale | 1,451 | $134K | Aug 22, 2026 |
| Sylvain Jereme M | officer | Sale | 1,451 | $134K | Aug 22, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →DXCM Growth Story
Revenue YoY
15.6%
3yr Revenue CAGR
17.0%
EPS Growth YoY
47.18%
FCF Growth YoY
70.8%
Revenue Trend
STRONG
Dark Pool Trades for DXCM
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for DXCM, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:25:45 | $80.34 | 5,640 | $$453K | BUY |
| 21:28:27 | $80.34 | 5,886 | $$473K | BUY |
| 21:00:27 | $80.34 | 1,582 | $$127K | BUY |
| 21:00:27 | $80.34 | 2,262 | $$182K | BUY |
| 21:00:25 | $80.34 | 3,202 | $$257K | BUY |
5 dark pool trades shown · $$1.5M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for DXCM
PREVIEWSEPT Investing provides real-time options flow tracking for DXCM, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $95 | Dec 18 | 37 | $$40 | 1 | SWEEP |
| PUT | $75 | Dec 18 | 37 | $$200 | 1 | SWEEP |
| CALL | $80 | Dec 18 | 37 | $$370 | 1 | SWEEP |
| CALL | $80 | Dec 18 | 37 | $$1480 | 4 | SWEEP |
| CALL | $80 | Dec 18 | 37 | $$1850 | 5 | SWEEP |
5 options trades shown · 80% calls
Unusual activity, GEX levels, max pain, and dealer positioning
What Traders Are Saying About DXCM
1 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for DXCM. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
SEPT Brain on $DXCM -- Neutral DXCM at $72.45. Day range $71.40-$73.66. Price testing zone top $72.50. Demand zone (77% institutional buying). Break above = buyers still pushing. Above $72.50, next z...
Join 3,500+ traders discussing DXCM in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for DEXCOM INC (DXCM) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →DXCM — frequently asked questions
What is DXCM stock price today?
DEXCOM INC (DXCM) is at $80.34, up 0.53% (+$0.42) at the Nov 11, 2026 close.
Why is DXCM stock moving today?
Latest DXCM news — Nov 10, 2026: Dexcom Inc filed an insider trading report (Form 4)
What is the DXCM price target?
The average analyst price target for DXCM is $95.00, ranging from $82 to $120, based on 17 analysts. Latest: JP Morgan maintains on Oct 30, 2026.
What do analysts rate DXCM?
Analyst ratings for DXCM: 2 Buy, 34 Hold, 0 Sell — consensus Hold.
Did DXCM beat earnings?
DXCM last reported on Oct 29, 2026: EPS $0.73 vs $0.68 expected — a beat of 8.1%.
What is DXCM's P/E ratio?
DXCM trades at a P/E of 31.4 vs a Healthcare average of 17.1.
Does DXCM pay a dividend?
DXCM does not currently pay a dividend.
What are DXCM support and resistance levels?
Support: $76.52, $73.10, $69.79. Resistance: $82.86, $86.75, $90.25.
What are insiders doing with DXCM?
Insider activity: SELLING, 0 buys and 12 sells in the last 90 days.
What is the latest news on DXCM?
Nov 10, 2026: Dexcom Inc filed an insider trading report (Form 4)